-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on Concentrix, Lowers Price Target to $54

Benzinga·03/24/2025 11:37:36
Listen to the news
Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:CNXC) with a Outperform and lowers the price target from $70 to $54.